Late Breaking Abstract - A randomized study to evaluate safety and pharmacokinetics of CT-P63 in healthy subjects

M. Tomaszewska-Kiecana (Jozefow, Poland), A. Wolowik (Jozefow, Poland), A. Kulesza (Jozefow, Poland), K. Ahn (Incheon, Republic of Korea), N. Jung (Incheon, Republic of Korea), Y. Lee (Incheon, Republic of Korea), J. Kim (Incheon, Republic of Korea), S. Kim (Incheon, Republic of Korea), M. Nowicki (Jozefow, Poland)

Source: International Congress 2022 – Fungal infections and other relevant COVID-19 findings

Session: Fungal infections and other relevant COVID-19 findings
Session type: Thematic Poster
Number: 1894

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Tomaszewska-Kiecana (Jozefow, Poland), A. Wolowik (Jozefow, Poland), A. Kulesza (Jozefow, Poland), K. Ahn (Incheon, Republic of Korea), N. Jung (Incheon, Republic of Korea), Y. Lee (Incheon, Republic of Korea), J. Kim (Incheon, Republic of Korea), S. Kim (Incheon, Republic of Korea), M. Nowicki (Jozefow, Poland). Late Breaking Abstract - A randomized study to evaluate safety and pharmacokinetics of CT-P63 in healthy subjects. 1894

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.